FDA approves capivasertib with fulvestrant for breast cancerMary Beth NierengartenCancerFebruary 23, 202410.1002/cncr.35238Cited by 38Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersNo related papers foundPowered by citation graph analysis